Trial Profile
QUILT-3.033: Haploidentical Donor Natural Killer (NK) Cell Infusion With Subcutaneous ALT-803 in Adults With Refractory or Relapsed Acute Myelogenous Leukemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Jul 2023
Price :
$35
*
At a glance
- Drugs Inbakicept (Primary) ; Cyclophosphamide; Fludarabine
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- Acronyms QUILT-3.033
- 30 Oct 2020 Status changed from active, no longer recruiting to completed.
- 13 Feb 2020 Status changed from suspended to active, no longer recruiting.
- 14 Sep 2018 Status changed from recruiting to suspendeddue to interim analysis